ReferIndia News Biocon Q4 profit drops 57%, but biosimilars business shines

ReferIndia News

ePrescribe

Upgrade your clinic to smart, simple, and paperless management—start today!

Know more
News Image

Biocon Q4 profit drops 57%, but biosimilars business shines

Published on: May 8, 2026, 11:12 a.m. | Source: The Hindu Business Line

Biocon's Q4 profit drops 57% due to exceptional items, but biosimilars and generics segments show strong growth.

Checkout more news
Ad Banner

Grow. Protect. Prosper.

Your wealth deserves expert care. Our advisors craft personalized investment plans designed to grow and safeguard your assets.

Schedule Call
ReferIndia News contact